AMAM(Delisted)
Ambrx BiopharmaยทNASDAQ
--
--(--)
AMAM Profile
Ambrx Biopharma, Inc.
A clinical stage biopharmaceutical company that developing antibody drug conjugates
10975 North Torrey Pines Road, La Jolla, California, United States 92037
--
Ambrx Biopharma, Inc., is a corporation organized under the laws of the State of Delaware. The Company is a clinical-stage biologics company focused on the discovery and development of a new class of engineered precision biologics (EPBs), leveraging its proprietary Extended Genetic Code technology platform that enables them to integrate synthetic amino acids (SAAs) into proteins within living cells in a site-specific manner. Their product candidates are designed to overcome the inherent limitations of traditional binding methods that use natural amino acids for non-site-specific binding, providing potential safety and efficacy benefits for the treatment of patients across multiple therapeutic areas.
